BNN.DE XETRA
BRAIN Biotech AG
1W: +3.6%
1M: +8.2%
3M: +1.8%
YTD: +26.8%
1Y: +31.4%
3Y: -35.8%
5Y: -72.1%
€2.89 ($3.23)
+0.04 (+1.40%)
Weekly Expected Move ±7.5%
€2
€3
€3
€3
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$50M
-9.2% ▼
5Y CAGR: +5.4%
Gross Profit
$2M
+400.2% ▲
5Y CAGR: -37.6%
Operating Income
-$9M
+3.9% ▲
Net Income
-$12M
-5.5% ▼
EPS (Diluted)
$-0.54
-5.9% ▼
EBITDA
-$4M
+1.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $38M | $50M | $55M | $55M | $50M |
| YoY Growth | +0.4% | +29.0% | +11.8% | -1.3% | -9.2% |
| Cost of Revenue | $40M | $48M | $52M | $54M | $48M |
| Gross Profit | -$2M | $1M | $3M | $401K | $2M |
| Gross Margin | -5.1% | 2.9% | 6.3% | 0.7% | 4.0% |
| R&D Expenses | $5M | $5M | $5M | $0 | $4M |
| SG&A Expenses | $3M | $4M | $5M | $5M | $7M |
| Operating Expenses | $6M | $9M | $10M | $39M | $11M |
| Operating Income | -$7M | -$8M | -$7M | -$9M | -$9M |
| Operating Margin | -17.1% | -15.2% | -12.1% | -16.2% | -17.1% |
| Interest Expense | $553K | $572K | $942K | $2M | $2M |
| Income Before Tax | -$4M | -$6M | -$7M | -$11M | -$12M |
| Tax Expense | $403K | $176K | $625K | $111K | -$190K |
| Net Income | -$5M | -$7M | -$8M | -$11M | -$12M |
| Net Margin | -13.0% | -13.3% | -15.0% | -20.4% | -23.7% |
| EPS (Diluted) | $-0.25 | $-0.30 | $-0.38 | $-0.51 | $-0.54 |
| EBITDA | $2M | -$1M | -$2M | -$4M | -$4M |
| Shares Outstanding | 20M | 22M | 22M | 22M | 22M |